Thompson Davis & Co’s Rosetta Genomics ROSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
– Sell
-83
Closed – – 1321
2014
Q2
$0 Buy
+83
New +$4.11K ﹤0.01% 925

Other funds holding ROSG

Thompson Davis & Co's ROSG Position: Q3 2014 in Review

Thompson Davis & Co sold out of Rosetta Genomics (ROSG) in Q3 2014, closing a stake of 83 shares.

Thompson Davis & Co first reported a position in ROSG in Q2 2014 and held it in 1 quarter. The position peaked at $0 in Q2 2014. 14 funds tracked by Wall St. Rank hold ROSG as of Q3 2014.

  • Thompson Davis & Co reported no remaining Rosetta Genomics position as of Q3 2014 after selling out during the quarter.
  • Thompson Davis & Co sold 83 Rosetta Genomics shares in Q3 2014.
  • Thompson Davis & Co first reported a position in Rosetta Genomics in Q2 2014 and held it in 1 quarter.
  • Thompson Davis & Co's Rosetta Genomics position peaked at $0 in Q2 2014.
  • 14 funds tracked by Wall St. Rank held Rosetta Genomics as of Q3 2014.

Based on Thompson Davis & Co's 13F filing for Q3 2014, filed 4 Nov 2014.